ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,362, issued on Dec. 16, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).
"Cyclopentapyrrole orexin receptor agonists" was invented by Stephane L. Bogen (Somerset, N.J.), Dane James Clausen (Rahway, N.J.), Michael T. Rudd (Collegeville, Pa.), Dong Xiao (Warren, N.J.) and Dexi Yang (Livingston, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to cyclopentapyrrole, furopyrrole and azabicycloheptane compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders ...